AllianceBernstein
NBP

AllianceBernstein’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

AllianceBernstein’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,916
Closed -$423K – 3292
2021
Q4 		$423K Sell
8,916
-1,562
-15% -$93.7K ﹤0.01% 2808
2021
Q3 		$760K Sell
10,478
-344
-3% -$24.9K ﹤0.01% 2602
2021
Q2 		$909K Buy
+10,822
New +$714K ﹤0.01% 2573

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein's NBP Position: Q1 2022 in Review

AllianceBernstein sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 8,916 shares — an estimated $423K sold.

AllianceBernstein first reported a position in NBP in Q2 2021 and held it in 3 quarters. The position peaked at $909K in Q2 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • AllianceBernstein reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • AllianceBernstein sold 8,916 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $423K.
  • AllianceBernstein first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 3 quarters.
  • AllianceBernstein's NovaBridge Biosciences American Depositary Shares position peaked at $909K in Q2 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on AllianceBernstein's 13F filing for Q1 2022, filed 13 May 2022.